Taiho Oncology, Inc. - Commercial

Princeton,  NJ 
United States
https://www.taihooncology.com

• Booth: 2089a

Taiho Oncology, Inc., a subsidiary of Taiho Pharmaceutical Co., Ltd. and Otsuka Holdings Co., Ltd., has established a world class clinical development organization that works urgently to develop innovative cancer treatments and has built a commercial business in the U.S. Taiho has an oral oncology pipeline consisting of both novel antimetabolic agents and selectively targeted agents. Advanced technology, dedicated researchers, and state of the art facilities are helping us to define the way the world treats cancer. It’s our work; it’s our passion; it’s our legacy.

Brands: https://events.jspargo.com/ASCO21/CUSTOM/LON-PM-US-1539_Lonsurf_2021_StaticBanners-Oral%20Treatment_728x90_v0.jpg

 Press Releases

• 02. INQOVI® (decitabine and cedazuridine) 35mg/100mg tablets Interactive Booth (Apr 14, 2021)

  https://taiho.protoexpo.com/commercial

• 01. LONSURF ® (trifluridine and tipiracil) tablets Fact or Fiction Mythbusters Game (Apr 14, 2021)
  https://www.knowyourlonsurf.com/index.html

• 06. Lonsurf Website (Apr 15, 2021)
  https://www.lonsurf.com/

• 07. Inqovi Website (Apr 15, 2021)
  https://www.inqovi.com/

• 05. Lonsurf Patient Starter Kit Flashcard (Apr 19, 2021)
  https://events.jspargo.com/ASCO21/CUSTOM/Lonsurf%20PSK%20Flashcard%20(Digital%20PDF).pdf

• 03. Lonsurf Efficacy Flashcard (Apr 19, 2021)
  https://events.jspargo.com/ASCO21/CUSTOM/Lonsurf%20Efficacy%20Flashcard%20-%20Digital%20PDF.pdf

• 04. Lonsurf Dosing Flashcard (Apr 19, 2021)
  https://events.jspargo.com/ASCO21/CUSTOM/Lonsurf%20Dosing%20Flashcard%20(Digital%20PDF).pdf

• 08. Inqovi Patient Access Brochure (Apr 19, 2021)
  https://events.jspargo.com/ASCO21/CUSTOM/INQOVI%20Patient%20Access%20Brochure_Digital.pdf

• 09. Inqovi Core Leave Behind (Apr 19, 2021)
  https://events.jspargo.com/ASCO21/CUSTOM/INQOVI_Core%20Leave%20Behind_wPI.pdf

• 10. Inqovi Dosing and Efficacy Leave Behind (Apr 19, 2021)
  https://events.jspargo.com/ASCO21/CUSTOM/INQOVI_Dosing%20and%20Efficacy_LB_w_PI.pdf